Museum Centre Vapriikki: A Finnish study reveals: Longer breastfeeding in the Middle Ages – Weaning began at age one in the 1800s
A research project launched by the Museum Centre Vapriikki has shed new light on infant feeding practices in medieval and early modern Finland. Led by PhD Tiina Väre and PhD Ulla Nordfors—a bioarchaeologist at Vapriikki and the University of Turku—the study examined early childhood diets using isotopic analysis of teeth from 13th–19th century individuals buried at the ruined St. Michael’s Church in Pälkäne. The results were published in Journal of Archaeological Science: Reports.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401865015/en/
According to a new study by Vapriikki, individuals who lived to adulthood in the Middle Ages received breast milk until they were over two years old. Photo: Ulla Nordfors
All studied individuals had been breastfed in infancy, but the timing of weaning differed. Individuals who survived into adulthood during the medieval period had received breast milk beyond the age of two, whereas those who died in childhood during the 18th and 19th centuries had been weaned by the age of one.
“Our sample size is small, only six individuals, because organic material rarely survives in Finland’s acidic soil. Although broad generalizations cannot be made, we can still explore individual life stories,” notes Ulla Nordfors.
One case involved a child who died around the age of 2.5 in the early 1800s. Isotopic values in the child’s teeth indicated a decline in health before death. A notable shift in the values may suggest that breastfeeding was resumed in an attempt to treat illness, as breast milk was believed to have healing properties.
“Alternatively, the brief initial breastfeeding period followed by a return to nursing could reflect the birth of a younger sibling. Previous research has shown that the arrival of a new baby within two years increased the mortality risk for the older child,” Nordfors adds.
In early 19th-century Finland, breastfeeding was increasingly supplemented with cow’s milk, delivered through milk horns. These devices were difficult to clean and exposed infants to serious infections. Infant mortality remained high until the end of the 1800s.
“Interdisciplinary archaeology can bring out deeply human aspects of the past. This research gives us a rare glimpse into childcare practices and how families may have responded to children's illnesses,” says Nordfors.
Research publication:
Väre, T. & Nordfors, U. 2025. Early childhood diets in Medieval and Post-Medieval Pälkäne, Finland: Insights from stable isotope analysis. Journal of Archaeological Science: Reports.
https://authors.elsevier.com/sd/article/S2352-409X(25)00146-4
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401865015/en/
Contacts
Contact information:
Ulla Nordfors, ulla.nordfors@tampere.fi, +358406681312
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Reply Announces the Jury for the First AI Music Contest: Finalists Will Perform Live on Stage at Kappa FuturFestival in Turin23.5.2025 11:05:00 EEST | Press release
Reply, an international group specialized in the creation of new business models enabled by Artificial Intelligence and driven by a strong culture of innovation, is expanding its creative experimentation initiatives this year with the launch of the AI Music Contest. Organised in collaboration with Kappa FuturFestival, one of Europe’s leading electronic music festivals, the competition is open to creatives and innovators who use AI technologies to explore new forms of integration between sound and visuals. It aims to enhance the expressive potential of artificial intelligence in live performances. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250523250887/en/ The jury members include prominent figures such as Seth Troxler and DJ Tennis, who are renowned DJs and producers known for their pioneering use of AI in live performances. Also on the panel is Albertino, a DJ, radio host and the artistic director of Radio m2o. Alongsid
Kioxia Holdings Corporation Wins IPO of the Year Award in the Equity Category at the DealWatch Awards 202423.5.2025 10:00:00 EEST | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced that it had won the IPO of the Year award in the Equity category at the DealWatch Awards 2024, organized by DealWatch, the most authoritative source of real-time intelligence for deal activity within Japan's capital markets. The award was presented at a ceremony held on May 20. The DealWatch Awards recognize outstanding issuers of bonds or equities in the Japanese capital market, as well as Japanese issuers who have conducted offerings overseas, and the securities firms that manage these transactions. The awards for 2024 comprised six categories: Overall, Bonds, Local Government Bonds, Cross-Border Bonds, Sustainable Finance, and Equity. Selection is based on criteria such as the appropriateness of pricing in the issuance market, price formation after transition to the trading market, contribution to the development of capital markets, and innovative efforts, with the awards designed to promot
Generix Named in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS) for the Seventh Consecutive Year23.5.2025 10:00:00 EEST | Press release
Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces it has been recognized by Gartner in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS). This is the seventh consecutive year that Generix has been recognized for its portfolio of WMS Solutions. Designed to scale as supply chain operations grow from simple to complex flows, Generix WMS and Solochain WMS are currently in more than 2,000 warehouses globally. “We are honored to be recognized in the Gartner® Magic Quadrant™ WMS for the seventh consecutive year. Generix continues its commitment to providing WMS for every warehousing need at a global scale. With our two recognized WMS solutions, Generix WMS and Solochain WMS, we continue to innovate to better serve customer needs with the introduction of industry game-changing AI use-cases such as resource planning and computer vision,” said Si-Mohamed Sa
NuORDER by Lightspeed and Mandatory Renew Partnership to Power Hybrid Commerce at the Third Edition of the Copenhagen Event23.5.2025 10:00:00 EEST | Press release
Mandatory and NuORDER by Lightspeed, the industry’s leading B2B commerce platform, are joining forces for the third consecutive time to power the digital extension of Mandatory’s in-person trade event, taking place August 5–7 in Copenhagen. This renewed partnership reflects the continued momentum behind hybrid commerce—where physical and digital trade intersect to create smarter, more flexible buying experiences. As the Nordic fashion ecosystem expands with energy and innovation, Mandatory has become a magnet for trendsetting brands and forward-looking retailers. On NuORDER’s wholesale platform, buyer activity from Nordic-region retailers surged by 39.4% year over year in Q1 2025 (January to March). "Retailers in the Nordic region have been quick to adopt digital tools to enhance the efficiency of their buying processes. The increase in buyer activity on the NuORDER platform early this year clearly indicates a growing market demand and a renewed engagement within the industry," said Ch
Curatis discloses Corticorelin as active substance of C-PTBE-0123.5.2025 08:00:00 EEST | Press release
An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute significantly to the quality of life of many patients, combined with the potential of maintaining the efficacy of immunotherapies for these patients, is very motivating and exciting,” said Dr. Roland Rutschmann, Curatis CEO. Key statements Corticorelin (hCRH), a 41 amino acid endogenous polypeptide, has demonstrated the ability to positively impact the blood-brain barrier after a disruption due to the underlying malignant tumor. Curatis intends to develop corticorelin to treat PTBE in primary and metasta
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom